Home » Thought Leadership » Podcasts » CBPartners’ Pharma Take-Away…

CBPartners’ Pharma Take-Away: COVID-19 (Pt 2): Promising Treatments in Development

April 21, 2020


Written by: Jared Louis Wolff Matthew Rube Akhil Parlapalli

In Part 2 of the COVID-19 series, healthcare consultant Jared Wolff is again joined by Matthew Rube and Akhil Parlapalli from CBPartners’ New York office to discuss some of the most promising treatments that are currently being put to the test against COVID-19. These include:

  • REMDESIVIR, Gilead
  • Hydroxychloroquine + azithromycin (Z-Pak), Pfizer
  • ·A more novel approach by Distributed Bio

Apple Podcasts